Business
Block Listing Interim Review
Block Listing Interim Review.
About this update from Eco Animal Health Group Plc
[{"type":"text","content":"\n\n \n \n \nECO Animal Health Group PLC\n \nBLOCK LISTING RETURN\n \nDate: 12 August 2024\n \n\n\n\n\nName of applicant:\n\n\nECO Animal Health Group plc\n\n\n\n\nName of scheme:\n\n\nExecutive Share Option Scheme and Unapproved Share Option Scheme\n\n\n\n\nNumber and class of securities originally listed and the date of admission:\n\n\n1,500,000 ordinary shares of 5 pence each on 20 July 2017\n\n\n\n\nPeriod of return:\n\n\nFrom:\n\n\n09 February 2024\n\n\nTo:\n\n\n09 August 2024\n\n\n\n\nBalance of unallotted securities under scheme(s) from previous return:\n\n\n375,505\n\n\n\n\nPlus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):\n\n\n0\n\n\n\n\nLess: Number of securities issued/allotted under scheme(s) during period:\n\n\n0\n\n\n\n\nEquals: Balance under scheme(s) not yet issued/allotted at end of period:\n\n\n375,505\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n-Ends-\nFor further information please contact:\n \n\n\n\n\n\n\n\n\nECO Animal Health Group plc\nDavid Hallas (CEO)\nChristopher Wilks (CFO)\n\n\n\n020 8447 8899\n \n\n\n\n\nSinger Capital Markets (Nominated Adviser & Joint Broker)\nPhil Davies\nSam Butcher\n\n\n020 7496 3000\n\n\n\n\nInvestec (Joint Broker)\nGary Clarence\nLydia Zychowska\n\n\n020 7597 5970\n \n \n\n\n\n\nEquity Development\nHannah Crowe\nMatt Evans\n\n\n020 7065 2692\n\n\n\n\nICR Consilium (Financial PR)\nMary-Jane Elliott\nJessica Hodgson\n\n\n020 3709 5700\[email protected]\n \n\n\n\n\n\n\n\n\n\n\n\n\nAbout ECO Animal Health\nECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.\nHeadquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.\nOur lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry. \nClick here for more information: https://ecoanimalhealth.com\n \n\n","length":7...